Structural and inflammatory heterogeneity in subcutaneous adipose tissue: Relation with liver histopathology in morbid obesity

Journal of Hepatology

Volumn 56, Issue 5, 2012, Pages 1152-1158

  Tordjman, Joan ^a,b,c   Divoux, Adeline ^b,c   Prifti, Edi ^b,c   Poitou, Christine ^a,b,c,d   Pelloux, Veronique ^a,b,c   Hugol, Danielle ^e   Basdevant, Arnaud ^a,b,c,d   Bouillot, Jean Luc ^e   Chevallier, Jean Marc ^f   Bedossa, Pierre ^g,h   Guerre Millo, Michèle ^a,b,c   Clement, Karine ^a,b,c,d  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b CENTRE DE RECHERCHE DES CORDELIERS   (France)

^c SORBONNE UNIVERSITÉ   (France)

^d CENTRE MAURICE HALBWACHS   (France)

^e HÔTEL DIEU   (France)

^f HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^g BEAUJON HOSPITAL   (France)

^h CENTRE DE RECHERCHE BIOMÉDICALE BICHAT BEAUJON CRB3   (France)

Author keywords

Bile acids; Cholestasis; Fatty liver disease; Gallstones; Liver cancer; Liver regeneration

Indexed keywords

COLLAGEN TYPE 4; COLLAGEN TYPE 4 ALPHA 1; COLONY STIMULATING FACTOR; COLONY STIMULATING FACTOR 3; CXCL2 CHEMOKINE; CXCL3 CHEMOKINE; CYSTEINE RICH PROTEIN 61; FIBRIC ACID DERIVATIVE; GLUCOSE TRANSPORTER 3; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; HLA DR ANTIGEN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; INTERLEUKIN 6; METFORMIN; MONOCYTE CHEMOTACTIC PROTEIN 2; SCAVENGER RECEPTOR B; SCAVENGER RECEPTOR B2; TAPASIN; THROMBOSPONDIN 1; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG; UROKINASE RECEPTOR;

ADULT; ARTICLE; BARIATRIC SURGERY; BODY MASS; DEEP SUBCUTANEOUS ADIPOSE TISSUE; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INSULIN TREATMENT; INTRAABDOMINAL FAT; LIVER BIOPSY; LIVER INJURY; MACROPHAGE; MALE; MORBID OBESITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; SUBCUTANEOUS FAT; SUPERFICIAL SUBCUTANEOUS ADIPOSE TISSUE;

ADULT; BIOPSY; FEMALE; FIBROSIS; HUMANS; INFLAMMATION; LIVER; MACROPHAGES; MALE; MIDDLE AGED; OBESITY, MORBID; SUBCUTANEOUS FAT;

EID: 84859701943     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2011.12.015     Document Type: Article

References (34)

1. Lafontan M, Girard J. Impact of visceral adipose tissue on liver metabolism. Part I: heterogeneity of adipose tissue and functional properties of visceral adipose tissue. Diabetes Metab 2008;34:317-327.
2. Cancello R, Tordjman J, Poitou C, Guilhem G, Bouillot JL, Hugol D, et al. Increased infiltration of macrophages in omental adipose tissue is associated with marked hepatic lesions in morbid human obesity. Diabetes 2006;55:1554-1561. (Pubitemid 44324107)
3. Harman-Boehm I, Bluher M, Redel H, Sion-Vardy N, Ovadia S, Avinoach E, et al. Macrophage infiltration into omental versus subcutaneous fat across different populations: effect of regional adiposity and the comorbidities of obesity. J Clin Endocrinol Metab 2007;92:2240-2247. (Pubitemid 46997129)
4. Tordjman J, Poitou C, Hugol D, Bouillot JL, Basdevant A, Bedossa P, et al. Association between omental adipose tissue macrophages and liver histopathology in morbid obesity: influence of glycemic status. J Hepatol 2009;51:354-362.
5. Smith SR, Lovejoy JC, Greenway F, Ryan D, DeJonge L, de la Bretonne J, et al. Contributions of total body fat, abdominal subcutaneous adipose tissue compartments, and visceral adipose tissue to the metabolic complications of obesity. Metabolism 2001;50:425-435. (Pubitemid 32321951)
6. Kelley DE, Thaete FL, Troost F, Huwe T, Goodpaster BH. Subdivisions of subcutaneous abdominal adipose tissue and insulin resistance. Am J Physiol Endocrinol Metab 2000;278:E941-E948. (Pubitemid 30366413)
7. Walker GE, Verti B, Marzullo P, Savia G, Mencarelli M, Zurleni F, et al. Deep subcutaneous adipose tissue: a distinct abdominal adipose depot. Obesity (Silver Spring) 2007;15:1933-1943. (Pubitemid 47402225)
8. Alvehus M, Buren J, Sjostrom M, Goedecke J, Olsson T. The human visceral fat depot has a unique inflammatory profile. Obesity (Silver Spring) 2010;18:879-883.
9. Poitou C, Coupaye M, Laaban JP, Coussieu C, Bedel JF, Bouillot JL, et al. Serum amyloid A and obstructive sleep apnea syndrome before and after surgically-induced weight loss in morbidly obese subjects. Obes Surg 2006;16:1475-1481. (Pubitemid 44759981)
10. Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 1999;94:2467-2474. (Pubitemid 29420675)
11. Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005;41:1313-1321. (Pubitemid 40770284)
12. Brunt EM, Kleiner DE, Wilson LA, Belt P, Neuschwander-Tetri BA. Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings. Hepatology 2011;53:810-820.
13. Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000;85:2402-2410. (Pubitemid 32269192)
14. Smyth GK, Speed T. Normalization of cDNA microarray data. Methods 2003;31:265-273. (Pubitemid 37338763)
15. Carey VJ, Gentry J, Whalen E, Gentleman R. Network structures and algorithms in bioconductor. Bioinformatics 2005;21:135-136.
16. Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 2001;98:5116-5121. (Pubitemid 32397092)
17. Henegar C, Tordjman J, Achard V, Lacasa D, Cremer I, Guerre-Millo M, et al. Adipose tissue transcriptomic signature highlights the pathological relevance of extracellular matrix in human obesity. Genome Biol 2008;9:R14.
18. Prifti E, Zucker JD, Clement K, Henegar C. FunNet: an integrative tool for exploring transcriptional interactions. Bioinformatics 2008;24:2636-2638.
19. Zhang B, Horvath S. A general framework for weighted gene co-expression network analysis. Stat Appl Genet Mol Biol 2005;4. Article 17.
20. Emanuelsson O, Brunak S, von Heijne G, Nielsen H. Locating proteins in the cell using TargetP, SignalP and related tools. Nat Protoc 2007;2:953-971. (Pubitemid 46745592)
21. Bendtsen JD, Jensen LJ, Blom N, Von Heijne G, Brunak S. Feature-based prediction of non-classical and leaderless protein secretion. Protein Eng Des Sel 2004;17:349-356. (Pubitemid 39093515)
22. Anderson NL, Polanski M, Pieper R, Gatlin T, Tirumalai RS, Conrads TP, et al. The human plasma proteome: a nonredundant list developed by combination of four separate sources. Mol Cell Proteomics 2004;3:311-326.
23. Nishimura S, Manabe I, Nagasaki M, Eto K, Yamashita H, Ohsugi M, et al. CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat Med 2009;15:914-920.
24. Liu J, Divoux A, Sun J, Zhang J, Clement K, Glickman JN, et al. Genetic deficiency and pharmacological stabilization of mast cells reduce dietinduced obesity and diabetes in mice. Nat Med 2009;15:940-945.
25. Di Gregorio GB, Yao-Borengasser A, Rasouli N, Varma V, Lu T, Miles LM, et al. Expression of CD68 andmacrophage chemoattractant protein-1 genes in human adipose and muscle tissues: association with cytokine expression, insulin resistance, and reduction by pioglitazone. Diabetes 2005;54:2305-2313. (Pubitemid 41134256)
26. Makkonen J, Westerbacka J, Kolak M, Sutinen J, Corner A, Hamsten A, et al. Increased expression of the macrophage markers and of 11beta-HSD-1 in subcutaneous adipose tissue, but not in cultured monocyte-derived macrophages, is associated with liver fat in human obesity. Int J Obes (Lond) 2007;31:1617-1625. (Pubitemid 47482653)
27. Apovian CM, Bigornia S, Mott M, Meyers MR, Ulloor J, Gagua M, et al. Adipose macrophage infiltration is associated with insulin resistance and vascular endothelial dysfunction in obese subjects. Arterioscler Thromb Vasc Biol 2008;28:1654-1659.
28. Cancello R, Henegar C, Viguerie N, Taleb S, Poitou C, Rouault C, et al. Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss. Diabetes 2005;54:2277-2286. (Pubitemid 41134253)
29. Tordjman J, Poitou C, Hugol D, Bouillot JL, Basdevant A, Bedossa P, et al. Association between omental adipose tissue macrophages and liver histopathology in morbid obesity: influence of glycemic status. J Hepatol 2009;51:354-362.
30. Cancello R, Taleb S, Poitou C, Tordjman J, Lacasa D, Guerre-Millo M, et al. Is obesity an inflammatory disease?. Journ Annu Diabetol Hotel Dieu 2006:115-128.
31. Fontana L, Eagon JC, Trujillo ME, Scherer PE, Klein S. Visceral fat adipokine secretion is associated with systemic inflammation in obese humans. Diabetes 2007;56:1010-1013. (Pubitemid 46525079)
32. Cancello R, Rouault C, Guilhem G, Bedel JF, Poitou C, Di Blasio AM, et al. Urokinase plasminogen activator receptor in adipose tissue macrophages of morbidly obese subjects. Obes Facts 2011;4:17-25.
33. Ghosh AK, Vaughan DE. PAI-1 in tissue fibrosis. J Cell Physiol 2011;227:493-507.
34. Liu W, Xu G, Ma J, Jia W, Li J, Chen K, et al. Osteopontin as a key mediator for vasculogenic mimicry in hepatocellular carcinoma. Tohoku J Exp Med 2011;224:29-39.